HIV-positive child with epidermodysplasia verruciformis-like lesions and homozygous mutation in TMC6

AIDS

Volumn 24, Issue 17, 2010, Pages 2758-2760

  Burger, Bettina ^a   Kind, Fabiola ^a   Spoerri, Iris ^a   Rütten, Arno ^b   Battegay, Manuel ^a   Häusermann, Peter ^a   Itin, Peter H ^a   Arnold, Andreas W ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; CASE REPORT; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TMC 6 GENE;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HIV INFECTIONS; HUMANS; MEMBRANE PROTEINS;

EID: 78349231284     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833fdfca     Document Type: Letter

References (14)

1. Orth G. Epidermodysplasia verruciformis: a model for under-standing the oncogenicity of human papillomaviruses. Ciba Found Symp 1986; 120:157-174.
2. Lewandowsky F, Lutz W. [A case of a not previously described skin disease (epidermodysplasia verruciformis)]. Arch Derma-tolSyph 1922; 141:193-203.
3. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32:579-581.
4. Hohenstein E, Rady PL, Hergersberg M, Huber AR, Tyring SK, Bregenzer T, et al. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-T polymorphism in the TMC8/EVER2 gene. Dermatology 2009; 218:114-118.
5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-asso-ciated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
6. Gormley RH, Kovarik CL. Dermatologic manifestations of HPV in HIV-infected individuals. Curr HIV/AIDS Rep 2009; 6:130-138.
7. Berk DR, Bruckner AL, Lu D. Epidermodysplasia verruciform-like lesions in an HIV patient. Dermatol Online J 2009; 15:1.
8. Bonamigo R, Maldonado G, Londero RM, Cartell A. Epidermo-dysplasia verruciformis-like disorder in a teenager with HIV and HCV infections. Pediatr Dermatol2007; 24:456-457.
9. Chen PJr, Kamino H, Walters RF, Rosenman K, Pomeranz MK, Sanchez M. Epidermodysplasia verruciformis in the setting of HIV infection. Dermatol Online J 2008; 14:1.
10. Maurer TA, Christian KV, Kerschmann RL, Berzin B, Palefsky JM, Payne D, et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 1997; 133:577-583.
11. Morrison C, Eliezri Y, Magro C, Nuovo GJ. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol 2002; 29:480-489.
12. Rallis E, Paparizos V, Kyriakis K, Katsambas A. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients. J Eur Acad Dermatol Venereol 2009; 23:195-196.
13. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, Grossman ME.Acquiredepidermodysplasiaverruciformis. J Am Acad Dermatol 2009; 60:315-320.
14. Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 2008; 122:2377-2379